A detailed history of Powell Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Powell Investment Advisors, LLC holds 8,653 shares of BMY stock, worth $470,030. This represents 0.21% of its overall portfolio holdings.

Number of Shares
8,653
Previous 8,653 -0.0%
Holding current value
$470,030
Previous $359,000 24.51%
% of portfolio
0.21%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $335 - $198,247
2,580 Added 42.48%
8,653 $615,000
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $9,719 - $10,584
-157 Reduced 2.52%
6,073 $406,000
Q1 2021

Apr 14, 2021

SELL
$59.34 - $66.74 $18,632 - $20,956
-314 Reduced 4.8%
6,230 $396,000
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $322,030 - $420,059
6,544 New
6,544 $420,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Powell Investment Advisors, LLC Portfolio

Follow Powell Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Powell Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powell Investment Advisors, LLC with notifications on news.